Ticker ASMB – Assembly Biosciences – sales, description, marketcap – Tickerday.com

ASMB

Assembly Biosciences

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 545.72M; Volume: 45.96K; AvgVol 3m: 229.07K; Beta: 1.21;

Cost estimate:

P/E: –; EPS: -2.51; EPS growth quarter/prev quarter: 127.10%;

EPS growth this year: 6.60%; EPS growth past 5 years: -1.80%;

EPS ttm: -2.51;

P/S: 10.64; P/B: 2.15; P/Cashflow: 2.46; P/FCF: ;

Sales: 52.46M; Sales growth quarter/prev quarter: 1178.40%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -24.40%; ROE – return on equity: -30.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.60%; Insider Transactions:-5.56%;

Institutional Ownership: 93.50%; Institutional Transactions: 3.71%;

Data update: 07/10/2020.